Comparison of gadolinium and AAV9-GFP distributions in the brain following focused ultrasound-mediated delivery across the BBB
Physics in Medicine & Biology · 2026
DOI: 10.1088/1361-6560/ae2cdc ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Physics in Medicine & Biology, 2026. Verfasst von Nick Todd und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America. Hauptthemen laut MEDLINE: Dependovirus, Green Fluorescent Proteins, Blood-Brain Barrier, Gadolinium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: NINDS NIH HHS, NIH.
Abstract (Originalsprache)
Focused ultrasound (FUS)-mediated blood-brain barrier (BBB) opening is a promising strategy for enhancing the delivery of gene therapies to the central nervous system. While gadolinium-based contrast MRI is commonly used to assess BBB disruption following FUS treatment, it remains unclear how well this surrogate marker predicts the distribution and efficacy of adeno-associated virus (AAV) delivery. In this study, we directly compared the spatial distributions of gadolinium contrast and AAV9-mediated green fluorescent protein (GFP) expression in the mouse brain following FUS-BBB opening. Thirty-eight mice were treated with varying FUS parameters and post-treatment injection timings. Gadolinium-based MRI was acquired acutely, and GFP expression was assessed three weeks later via immunofluorescent imaging. The two imaging modalities were co-registered to a common MRI template to enable voxel-wise comparisons. While GFP expression was generally confined to regions with gadolinium signal enhancement, the area of contrast enhancement consistently exceeded the area of AAV transduction. The degree of spatial overlap and signal correlation varied across experimental conditions. Timing of AAV injection post-FUS had a notable impact on GFP expression with reduce areas with increased time post injection, whereas variations in FUS harmonic dose and microbubble dose had no significant effects. These results suggest that contrast-enhanced MRI provides a useful but imperfect predictor of AAV delivery and highlight the need to better understand the mechanisms underlying AAV transport across the BBB following FUS treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America.
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States of America.
ORCID-Profile: Nick Todd, Stecia-Marie P Fletcher, Nathan McDannold
Förderung
- NINDS NIH HHS
- NIH
Zitieren
APA
Todd, N., Owusu-Yaw, B., Fletcher, S. P., Zhang, Y., McDannold, N., & Kegel-Gleason, K. (2026). Comparison of gadolinium and AAV9-GFP distributions in the brain following focused ultrasound-mediated delivery across the BBB. Physics in Medicine & Biology. https://doi.org/10.1088/1361-6560/ae2cdc
Vancouver
Todd N, Owusu-Yaw B, Fletcher SP, Zhang Y, McDannold N, Kegel-Gleason K. Comparison of gadolinium and AAV9-GFP distributions in the brain following focused ultrasound-mediated delivery across the BBB. Physics in Medicine & Biology. 2026. doi:10.1088/1361-6560/ae2cdc
BibTeX
@article{Todd2026,
author = {Todd, Nick and Owusu-Yaw, Bernie and Fletcher, Stecia-Marie P and Zhang, Yongzhi and McDannold, Nathan and Kegel-Gleason, Kimberly},
title = {Comparison of gadolinium and AAV9-GFP distributions in the brain following focused ultrasound-mediated delivery across the BBB},
journal = {Physics in Medicine & Biology},
year = {2026},
doi = {10.1088/1361-6560/ae2cdc}
}
EUVIMED